126 related articles for article (PubMed ID: 7881462)
1. Frequent deletions and sequence aberrations at the transgene junctions of transgenic mice carrying the papillomavirus regulatory and the SV40 TAg gene sequences.
Chen CM; Choo KB; Cheng WT
Transgenic Res; 1995 Jan; 4(1):52-9. PubMed ID: 7881462
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of chromosomal integration of transgenes in microinjected mouse eggs: sequence analysis of genome-transgene and transgene-transgene junctions at two loci.
Hamada T; Sasaki H; Seki R; Sakaki Y
Gene; 1993 Jun; 128(2):197-202. PubMed ID: 8390388
[TBL] [Abstract][Full Text] [Related]
3. Expression of a fusion gene consisting of the mouse growth hormone-releasing hormone gene promoter linked to the SV40 T-antigen gene in transgenic mice.
Nogues N; Magnan E; De Grandis P; Butz M; Kineman RD; Kopchick JJ; Frohman LA
Mol Cell Endocrinol; 1998 Feb; 137(2):161-8. PubMed ID: 9605518
[TBL] [Abstract][Full Text] [Related]
4. Unregulated and basal transcriptional activities of the regulatory sequence of the type 18 human papillomavirus genome in transgenic mice.
Choo KB; Chong KY; Liew LN; Hsu HC; Cheng WT
Virology; 1992 May; 188(1):378-83. PubMed ID: 1314463
[TBL] [Abstract][Full Text] [Related]
5. A model for the mechanism of precise integration of a microinjected transgene.
McFarlane M; Wilson JB
Transgenic Res; 1996 May; 5(3):171-7. PubMed ID: 8673144
[TBL] [Abstract][Full Text] [Related]
6. Tissue-specific expression of kallikrein family transgenes in mice and rats.
Smith MS; Lechago J; Wines DR; MacDonald RJ; Hammer RE
DNA Cell Biol; 1992 Jun; 11(5):345-58. PubMed ID: 1605858
[TBL] [Abstract][Full Text] [Related]
7. Amplification of a SV40 T antigen transgene is associated with sarcomagenesis in mice.
Teitz T; Yen TS; Kan YW
Carcinogenesis; 1994 Sep; 15(9):2049-51. PubMed ID: 7923601
[TBL] [Abstract][Full Text] [Related]
8. Transgene integration and organization in cotton (Gossypium hirsutum L.) genome.
Zhang J; Cai L; Cheng J; Mao H; Fan X; Meng Z; Chan KM; Zhang H; Qi J; Ji L; Hong Y
Transgenic Res; 2008 Apr; 17(2):293-306. PubMed ID: 17549600
[TBL] [Abstract][Full Text] [Related]
9. Development of neuroepithelial tumors of the adrenal medulla in transgenic mice expressing a mouse hypothalamic growth hormone-releasing hormone promoter-simian virus-40 T-antigen fusion gene.
Pecori Giraldi F; Mizobuchi M; Horowitz ZD; Downs TR; Aleppo G; Kier A; Wagner T; Yun JS; Kopchick JJ; Frohman LA
Endocrinology; 1994 Mar; 134(3):1219-24. PubMed ID: 8119162
[TBL] [Abstract][Full Text] [Related]
10. Direct sequencing of PCR-amplified junction fragments from tandemly repeated transgenes.
Rohan RM; King D; Frels WI
Nucleic Acids Res; 1990 Oct; 18(20):6089-95. PubMed ID: 2172927
[TBL] [Abstract][Full Text] [Related]
11. Reconstitution of wild type viral DNA in simian cells transfected with early and late SV40 defective genomes.
O'Neill FJ; Gao Y; Xu X
Virus Res; 1993 Nov; 30(2):171-88. PubMed ID: 8249445
[TBL] [Abstract][Full Text] [Related]
12. Tissue specificity of L-pyruvate kinase transgenes results from the combinatorial effect of proximal promoter and distal activator regions.
Miquerol L; Cluzeaud F; Porteu A; Alexandre Y; Vandewalle A; Kahn A
Gene Expr; 1996; 5(6):315-30. PubMed ID: 8836739
[TBL] [Abstract][Full Text] [Related]
13. SV40 DNA in human osteosarcomas shows sequence variation among T-antigen genes.
Lednicky JA; Stewart AR; Jenkins JJ; Finegold MJ; Butel JS
Int J Cancer; 1997 Sep; 72(5):791-800. PubMed ID: 9311596
[TBL] [Abstract][Full Text] [Related]
14. Timely immunization subverts the development of peripheral nonresponsiveness and suppresses tumor development in simian virus 40 tumor antigen-transgenic mice.
Ye X; McCarrick J; Jewett L; Knowles BB
Proc Natl Acad Sci U S A; 1994 Apr; 91(9):3916-20. PubMed ID: 8171012
[TBL] [Abstract][Full Text] [Related]
15. Radiation-induced point mutations, deletions and micronuclei in lacI transgenic mice.
Winegar RA; Lutze LH; Hamer JD; O'Loughlin KG; Mirsalis JC
Mutat Res; 1994 Jun; 307(2):479-87. PubMed ID: 7514721
[TBL] [Abstract][Full Text] [Related]
16. Targeted pituitary tumorigenesis using the human thyrotropin beta-subunit chain promoter in transgenic mice.
Maki K; Miyoshi I; Kon Y; Yamashita T; Sasaki N; Aoyama S; Takahashi E; Namioka S; Hayashizaki Y; Kasai N
Mol Cell Endocrinol; 1994 Nov; 105(2):147-54. PubMed ID: 7859921
[TBL] [Abstract][Full Text] [Related]
17. Glucagon gene 5'-flanking sequences direct expression of simian virus 40 large T antigen to the intestine, producing carcinoma of the large bowel in transgenic mice.
Lee YC; Asa SL; Drucker DJ
J Biol Chem; 1992 May; 267(15):10705-8. PubMed ID: 1587847
[TBL] [Abstract][Full Text] [Related]
18. Transgene integration in hair follicles and peripheral blood cells measured by in vitro DNA amplification and fluorescence in situ hybridization.
Amendola R; Haendel S; Weier HU; Pallavicini MG
DNA Cell Biol; 1991 May; 10(4):311-7. PubMed ID: 2029339
[TBL] [Abstract][Full Text] [Related]
19. Transgene integration in aspen: structures of integration sites and mechanism of T-DNA integration.
Kumar S; Fladung M
Plant J; 2002 Aug; 31(4):543-51. PubMed ID: 12182710
[TBL] [Abstract][Full Text] [Related]
20. Transgene stability and features of rasH2 mice as an animal model for short-term carcinogenicity testing.
Suemizu H; Muguruma K; Maruyama C; Tomisawa M; Kimura M; Hioki K; Shimozawa N; Ohnishi Y; Tamaoki N; Nomura T
Mol Carcinog; 2002 May; 34(1):1-9. PubMed ID: 12112317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
